Diabetes decisions — 2025

The appeal for service connection for various conditions was dismissed due to the death of the Appellant.

The Board denied the Veteran's claim for an effective date prior to August 10, 2022, for the award of service connection for diabetes mellitus, type II, associated with herbicide exposure.

The Board denied service connection for prostate cancer, hypertension, diabetes mellitus, and sleep apnea as these conditions were not etiologically related to the Veteran's service, including exposure to ionizing radiation and TCE.

The Board remands the claims for service connection for a respiratory disorder, heart disorder, diabetes mellitus type II, and hypertension, as well as entitlement to a special monthly pension, due to insufficient evidence regarding in-service exposure to herbicide agents.

The Board denied service connection for diabetes mellitus as it did not begin during active service and is not otherwise related to an in-service injury or disease, including in-service toxic substance exposure.

The Board denied service connection for various conditions, including an acquired psychiatric disability, hearing loss, OSA, heart disease, and type two diabetes mellitus.

The Board denied service connection for diabetes mellitus, type II and diabetic peripheral neuropathy in the bilateral lower extremities as there was no evidence that these conditions began during active service or were otherwise related to an in-service injury or disease.

The Board remands the issue of entitlement to TDIU prior to August 9, 2023, as it is inextricably intertwined with other pending matters.

The Board granted service connection for diabetes mellitus, type II (DMII) as secondary to PTSD with substance use disorder, finding that the Veteran's DMII is aggravated beyond its natural progression by his service-connected PTSD and SUD.

The Board granted service connection for diabetes, coronary artery disease and old myocardial infarction, prostate cancer, left lower extremity diabetic neuropathy, right lower extremity diabetic neuropathy, erectile dysfunction, and special monthly compensation based on loss of use of a creative organ. The claims for service connection for a left leg skin disorder, vision disorder, and obstructive sleep apnea were denied.

The Board remands the claims for service connection for various conditions due to toxic exposure during service, as required by the PACT Act.

The Board has dismissed the claims for service connection for various conditions due to the Veteran's death during the pendency of the appeal.

The Veteran was granted an initial 100 percent disability rating for his service-connected coronary artery disease s/p artery disease graft and heart valve replacement with valvular heart disease, effective February 27, 2012. The appeal for a higher rating for diabetes mellitus prior to December 4, 2013, was denied.

The Board remands the issues of entitlement to service connection for diabetes mellitus and hypertension for further development, specifically to obtain an opinion on whether the Veteran's service-connected Bell's palsy aggravated his obesity which in turn caused or substantially contributed to his diabetes and hypertension.

The Board granted service connection for diabetes mellitus and cataracts, as secondary to the service-connected diabetes mellitus.

The Board denied the Veteran's claim for a TDIU prior to March 4, 2020, finding that his service-connected disabilities did not render him unable to secure or follow a substantially gainful occupation.

The Board granted service connection for bilateral sensorineural hearing loss disability but denied it for diabetes mellitus, type II.

The Board denied service connection for chronic lymphocytic leukemia, diabetes mellitus, and peripheral neuropathy in both lower extremities as there was no evidence of an in-service event, disease, or injury related to these conditions.

The Board denied an effective date prior to January 29, 2020, for the grant of service connection for type II diabetes mellitus and a rating in excess of 20 percent for the same condition.

The Board dismissed motions to revise on the basis of clear and unmistakable error (CUE) a July 2021 decision regarding earlier effective dates for service connection for various diabetic conditions.